HERA-CD27 Trademark

Trademark Overview


On Wednesday, May 8, 2019, a trademark application was filed for HERA-CD27 with the United States Patent and Trademark Office. The USPTO has given the HERA-CD27 trademark a serial number of 79262796. The federal status of this trademark filing is REGISTERED as of Tuesday, June 9, 2020. This trademark is owned by Apogenix AG. The HERA-CD27 trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Scientific services, namely, scientific and pharmaceutical research in the field of oncology and immunology relating to fusion proteins with tumor necrosis factor superfamily (TNF-SF) moiety; scientific and technological services, namely, protein design and protein engineering in the field of oncology and immunology relating to fusion proteins with tumor necrosis factor superfamily (TNF-SF) moiety; scientific consulting services in the field of protein design and protein engineering regarding fusion proteins with tumor necrosis factor superfamily (TNF-SF) moiety and providing scientific information in the field of protein design and protein engineering regarding fusion proteins with tumor necrosis factor superfamily (TNF-SF) moiety
hera-cd27

General Information


Serial Number79262796
Word MarkHERA-CD27
Filing DateWednesday, May 8, 2019
Status700 - REGISTERED
Status DateTuesday, June 9, 2020
Registration Number6071816
Registration DateTuesday, June 9, 2020
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 24, 2020

Trademark Statements


Pseudo MarkHERA-CD TWENTY SEVEN; HERA-CD TWO SEVEN
Goods and ServicesScientific services, namely, scientific and pharmaceutical research in the field of oncology and immunology relating to fusion proteins with tumor necrosis factor superfamily (TNF-SF) moiety; scientific and technological services, namely, protein design and protein engineering in the field of oncology and immunology relating to fusion proteins with tumor necrosis factor superfamily (TNF-SF) moiety; scientific consulting services in the field of protein design and protein engineering regarding fusion proteins with tumor necrosis factor superfamily (TNF-SF) moiety and providing scientific information in the field of protein design and protein engineering regarding fusion proteins with tumor necrosis factor superfamily (TNF-SF) moiety

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, July 16, 2019
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameApogenix AG
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressDE

Party NameApogenix AG
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressDE

Party NameApogenix AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressDE

Trademark Events


Event DateEvent Description
Thursday, July 11, 2019SN ASSIGNED FOR SECT 66A APPL FROM IB
Tuesday, July 16, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, July 20, 2019APPLICATION FILING RECEIPT MAILED
Monday, July 22, 2019ASSIGNED TO EXAMINER
Tuesday, July 23, 2019NON-FINAL ACTION WRITTEN
Wednesday, July 24, 2019NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Saturday, August 17, 2019REFUSAL PROCESSED BY MPU
Saturday, August 17, 2019NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, September 6, 2019REFUSAL PROCESSED BY IB
Tuesday, February 4, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, February 4, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, February 7, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, February 7, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, February 8, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, February 12, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 4, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 24, 2020PUBLISHED FOR OPPOSITION
Tuesday, March 24, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 9, 2020REGISTERED-PRINCIPAL REGISTER
Wednesday, September 9, 2020FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Wednesday, September 30, 2020FINAL DISPOSITION PROCESSED
Thursday, October 1, 2020FINAL DISPOSITION NOTICE SENT TO IB
Sunday, October 25, 2020FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, December 24, 2021NEW REPRESENTATIVE AT IB RECEIVED
Monday, June 9, 2025COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED